QuintilesIMS Real-World Insights Bibliography

Real-world Assessment of Renal Involvement in Tuberous Sclerosis Complex (TSC) Patients in the United Kingdom (UK): A Retrospective Cohort Study in the Clinical Practice Research Datalink (CPRD)
Author(s): Kingswood, Chris1, Nasuti, Paola2, Demuth, Dirk2, Patel, Keyur2, Myland, Melissa2, Erhard, Clement3, Gray, Elizabeth4, Pinnegar, Alun4, Magestro, Matthew5
Affiliations(s): The Royal Sussex County Hospital, Brighton, England 2 IMS Health, London, UK 3 CE Analytics, Cambridge, UK 4 Novartis Pharmaceuticals UK Ltd, Frimley, UK 5 Novartis Pharmaceuticals Corporation, East Hanover NJ, USA
Publication(s): International TSC Research Conference (Windsor, 11th Sept 2015).
Document Type(s): Poster
Countries: England
C:
Y:
Oncology, Pediatrics, Rare disease
2015
  L:
A:
English
Retrospective cohort analysis
  Add to report
 
 
Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype
Author(s): McKone EF, Goss C, Velentgas P, Swenson A
Affiliations(s): 
Publication(s): Journal of Cystic Fibrosis. JCF1155. Feb 2015. 10.1016(j.jcf.2015) 01.005
Document Type(s): Article
Countries: 
C:
Y:
Rare disease
2015
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles
  Add to report
 
 
Fifth interim analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER): Insights into management/practice in patients with PKU.
Author(s): Lagler FB, Muntau AC, Feillet F, Rogoff D, Moreau-Stucker F, Alm J, Burlina A, Trefz FK.
Affiliations(s): Quintiles Real-World and Late Phase Research
Publication(s): Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Congress, 1–4 September 2015, Lyon, France, Abstract No. P-160
Document Type(s): Abstract
Countries: 
C:
Y:
Patient Registries & Real-World Study Methods, Rare disease
2015
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles
  Add to report
 
 
Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE). Science Direct
Author(s): Recht N, Neufeld EJ, Sharma VR, Solem CT, Pickard S, Gut RZ, MD, Cooper DL
Affiliations(s): 
Publication(s): 
Document Type(s): Article
Countries: 
C:
Y:
Rare disease
2014
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles
  Add to report
 
 
Health-related Quality of Life in Patients with Hemophilia and Inhibitors on Prophylaxis with an Activated Prothrombin Complex Concentrate: Results From the Pro-FEIBA Study
Author(s): Gringeri A, Leissinger C,,Cortesi P, Jo H, Fusco F, Riva F, Bulent A, Berntorp E, Carpenter S, Kavakli K, Morfini M, Negrier C, Rocino A, Schramm W, Uscatescu M, Windyga J, Zulfikar B, Mantovani LG
Affiliations(s): 
Publication(s): Haemophilia 2013 Sep;19(5):736-43
Document Type(s): Article
Countries: 
C:
Y:
Rare disease
2013
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles
  Add to report
 
 
Impact of pregnancy on women with cystic fibrosis
Author(s): McMullen AH, Pasta DJ, Frederick PD, Konstan MW, Morgan WJ, Schechter MS, Wagener JS
Affiliations(s): 
Publication(s): Chest 2006; 129(3):706-711
Document Type(s): Article
Countries: 
C:
Y:
Rare disease
2006
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles
  Add to report